Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Defensin Interactions in Relation to Monoclonal and Disease-Related Proteinase 3 Antibodies Binding at the Catalytic Site. | Antibodies (Basel) | 2023 | 36975370 | PubTator, text mining | PubMed |
| S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung. | Acta Pharm Sin B | 2023 | 36970190 | PubTator, text mining | PubMed |
| Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States. | J Crohns Colitis | 2023 | 36961872 | PubTator, text mining | PubMed |
| Global detection of human variants and isoforms by deep proteome sequencing. | Nat Biotechnol | 2023 | 36959352 | PubTator, text mining | PubMed |
| High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy. | Ophthalmol Sci | 2023 | 36950301 | PubTator, text mining | PubMed |
| Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis. | Transl Neurodegener | 2023 | 36895045 | PubTator, text mining | PubMed |
| Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics. | BMC Nephrol | 2023 | 36894904 | PubTator, text mining | PubMed |
| Novel therapeutics for myelofibrosis. | Blood Res | 2023 | 36891574 | PubTator, text mining | PubMed |
| Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn's Disease. | Dig Dis Sci | 2023 | 36884186 | PubTator, text mining | PubMed |
| Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases. | Front Immunol | 2023 | 36875133 | PubTator, text mining | PubMed |
| Pentraxin 3 in the cerebrospinal fluid during central nervous system infections: A retrospective cohort study. | PLoS One | 2023 | 36862691 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| Multi-Omics Analyses Reveal the Mechanisms of Early Stage Kidney Toxicity by Diquat. | Toxics | 2023 | 36851058 | PubTator, text mining | PubMed |
| Inducible Nitric Oxide Synthase Embedded in Alginate/Polyethyleneimine Hydrogel as a New Platform to Explore NO-Driven Modulation of Biological Function. | Molecules | 2023 | 36838600 | PubTator, text mining | PubMed |
| Russian Registry of Idiopathic Pulmonary Fibrosis: Clinical Features, Treatment Management, and Outcomes. | Life (Basel) | 2023 | 36836792 | PubTator, text mining | PubMed |
| Differentially Expressed Genes and Molecular Susceptibility to Human Age-Related Diseases. | Int J Mol Sci | 2023 | 36835409 | PubTator, text mining | PubMed |
| Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases. | Comput Struct Biotechnol J | 2023 | 36817952 | PubTator, text mining | PubMed |
| Metabolomics profiling to characterize cerebral ischemia-reperfusion injury in mice. | Front Pharmacol | 2023 | 36814490 | PubTator, text mining | PubMed |
| CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer's Dementia Spectrum. | Int J Alzheimers Dis | 2023 | 36793451 | PubTator, text mining | PubMed |
| Long Pentraxin 3 as a New Biomarker for Diagnosis of Hip and Knee Periprosthetic Joint Infections. | J Clin Med | 2023 | 36769703 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=12